IDYAIDEAYA Biosciences, Inc.同业对比
IDEAYA Biosciences, Inc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDYA本股 | $3.0B#8 | — | 2.8x#3 | 13.8x#4 | 3024.4%#2 | 58.6%#4 | -72.8%#4 | -10.4%#4 | — | — | -0.2%#10 | — |
| ACAD | $3.5B#1 | 9.2x#1 | 2.7x#2 | 3.3x#3 | 11.9%#5 | 73.0%#2 | 9.8%#3 | 29.9%#1 | 11.4%#1 | — | -8.0%#13 | — |
| DYN | $3.4B#2 | — | 4.8x#9 | — | — | -40.6%#14 | — | -0.0%#3 | -1301.5%#9 | — | -25.1%#15 | — |
| VKTX | $3.3B#3 | — | 5.7x#12 | — | — | -227.1%#16 | — | -61.1%#13 | — | — | -27.5%#16 | — |
| ELVN | $3.3B#4 | — | 3.7x#5 | — | — | -16.5%#9 | — | -11.6%#5 | — | — | 122.4%#2 | — |
| AMLX | $3.3B#5 | — | 13.6x#14 | — | -100.0%#10 | 52.0%#5 | — | -60.5%#12 | — | — | 115.2%#4 | — |
| IRON | $3.1B#6 | — | 4.8x#10 | — | — | -94.0%#15 | — | -32.9%#9 | -39.0%#5 | — | -4.1%#11 | — |
| BHC | $3.0B#7 | — | — | 0.3x#1 | 6.7%#6 | 441.3%#1 | 17.7%#2 | — | 3.7%#3 | — | 33.2%#6 | 11.7%#1 |
| VRDN | $2.8B#9 | — | 4.3x#6 | 40.2x#7 | 23359.9%#1 | -26.9%#11 | -512.9%#7 | -51.7%#11 | -54.5%#6 | — | 8.6%#8 | — |
| NRIX | $2.8B#10 | 10.6x#2 | 2.9x#4 | 33.6x#6 | 54.0%#3 | -36.6%#12 | -340.2%#6 | -27.3%#8 | — | — | 104.8%#5 | — |
| MBX | $2.7B#11 | — | 6.5x#13 | — | — | -40.5%#13 | — | -21.2%#7 | — | — | 166.7%#1 | — |
| RCUS | $2.4B#12 | — | 5.2x#11 | 73.0x#8 | -35.3%#9 | -24.7%#10 | -1169.7%#8 | -76.1%#14 | -93.0%#8 | — | -7.0%#12 | — |
| BHVN | $2.4B#13 | — | — | — | — | 12.7%#7 | — | — | — | — | 5.1%#9 | — |
| PBH | $2.3B#14 | 13.9x#3 | 1.2x#1 | 2.2x#2 | -4.3%#7 | -11.3%#8 | 28.4%#1 | 9.9%#2 | 5.9%#2 | 4#1 | -18.2%#14 | — |
| IMNM | $2.3B#15 | — | 4.4x#7 | 332.7x#9 | -23.2%#8 | 27.5%#6 | -3228.8%#9 | -40.4%#10 | -72.8%#7 | — | 19.4%#7 | — |
| XNCR | $2.3B#16 | — | 4.5x#8 | 18.2x#5 | 13.7%#4 | 60.5%#3 | -141.4%#5 | -18.3%#6 | -31.5%#4 | — | 120.4%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议